Bargaining and the price of new pharmaceuticals in Australia: an empirical analysis

The primary aim of this study is to examine the factors that influence coverage of medicines on the national public insurance scheme and at what price. The study will be provide information on best way to negotiate prices to achieve value for money in pharmaceutical purchasing and provide answers to an important policy issue for the future design of health regulation and funding what is the trade-off between providing affordable health care using value based price regulation and timely access to care.